Global Pharma, Biopharma Patent Laws In Spotlight At CPhI’s Pharma IPR Conference in India 08/01/2014 by Intellectual Property Watch Leave a Comment Print This Post An upcoming conference in Mumbai, India will look at patent laws related to the pharmaceutical and biopharma industries regionally and internationally. CPhI’s 3rd Annual Pharma IPR 2014, taking place from 26-28 February, is a targeted conference focusing on patent related matters for pharma and biopharma industry across the globe. It is intended to provide an ideal learning and networking platform where techno-legal experts from patent law firms across the globe share an update on patent regimes, changes in patent laws, and enforceability of patent laws in different regions with the pharma and biopharma companies. The conference agenda will cover most debated subjects like: inter-partes review; one year after the implementation of the America Invents Act; reverse payments settlements cases; current implementation of the Unitary Patent System in the EU; and formulating strategies to introduce generic products in international markets. The programme will cover patent laws of over 13 regions including the US, EU, Japan, Mexico, Canada, India, South East Asia, and Gulf Corporation Council (GCC) countries. Click here to view the region-wise agenda. Free download for IP-Watch Readers! Click here to view presentations from 2013! Related Articles: Alert: Pharma IPR 2014 Conference In Mumbai, 26-28 February Infojustice: Graphics Show Rise In US Pharma Exports To India, Patent Grants By India Biopharma Industries, Others Urge Caution In US Patent Reform "Global Pharma, Biopharma Patent Laws In Spotlight At CPhI’s Pharma IPR Conference in India" by Intellectual Property Watch is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.